Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986-2009 memorial Sloan-Kettering cancer center experience

Thyroid

Volumn 23, Issue 8, 2013, Pages 997-1002

  Ibrahimpasic, Tihana ^a   Ghossein, Ronald ^a   Carlson, Diane L ^b   Chernichenko, Natalya ^a   Nixon, Iain ^a   Palmer, Frank L ^a   Lee, Nancy Y ^a   Shaha, Ashok R ^a   Patel, Snehal G ^a   Tuttle, R Michael ^a   Balm, Alfons J M ^c   Shah, Jatin P ^a   Ganly, Ian ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE;

ADJUVANT THERAPY; ADULT; AGED; CANCER CENTER; CANCER PATIENT; CANCER STAGING; CANCER SURGERY; CONFERENCE PAPER; DISEASE SPECIFIC SURVIVAL; DISTANT METASTASIS; ESOPHAGUS RESECTION; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; OVERALL SURVIVAL; POORLY DIFFERENTIATED THYROID CANCER; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; SUBTOTAL THYROIDECTOMY; THYROIDECTOMY; TREATMENT OUTCOME; UPPER RESPIRATORY TRACT;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 84883105746     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0403     Document Type: Conference Paper

References (26)

1. DeLellis RA, Lloyd RV, Heitz PU, Eng C (eds) 2004 World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs. IARC Press, Lyon.
2. Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, Katoh R, Lloyd RV, LiVolsi VA, Papotti M, Sobrinho-Simoes M, Bussolati G, Rosai J 2007 Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol 31:1256-1264.
3. Hiltzik D, Carlson D, Tuttle RM, Chuai S, Ishill N, Shaha A, Shah J, Singh B, Ghossein R 2006 Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer 106:1286-1295.
4. Wreesmann VB, Ghossein RA, Patel SG, Harris CP, Schnaser EA, Shaha AR, Tuttle RM, Shah JP, Rao PH, Singh B 2002 Genome-wide appraisal of thyroid cancer progression. Am J Pathol 161:1549-1556.
5. Tanaka K, Sonoo H, Yamamoto Y, Udagawa K, Arime I, Kunisue H, Yamamoto S, Kurebayashi J, Shimozuma K 1999 Analyses of the outcome of locally invasive papillary thyroid carcinomas. Thyroid 9:1017-1022.
6. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti AE 2010 AJCC Cancer Staging Manual. 7th edition. Springer, New York.
7. Volante M, Landolfi S, Chiusa L, Palestini N, Motta M, Codegone A, Torchio B, Papotti MG 2004 Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer 100:950-957.
8. Akslen LA, LiVolsi VA 2000 Poorly differentiated thyroid carcinoma - it is important. Am J Surg Pathol 24:310-313.
9. McCaffrey TV, Bergstralh EJ, Hay ID 1994 Locally invasive papillary thyroid carcinoma: 1940-1990. Head Neck 16: 165-172.
10. Ito Y, Miyauchi A, Jikuzono T, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Ichihara K, Kuma K 2007 Risk factors contributing to a poor prognosis of papillary thyroid carcinoma: validity of UICC/AJCC TNM classification and stage grouping. World J Surg 31:838-848.
11. Sanders EM Jr, LiVolsi VA, Brierley J, Shin J, Randolph GW 2007 An evidence-based review of poorly differentiated thyroid cancer. World J Surg 31:934-945.
12. Cody HS, Shah JP 1981 Locally invasive, well-differentiated thyroid cancer. 22 years' experience at Memorial Sloan- Kettering Cancer Center. Am J Surg 142:480-483.
13. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A 2006 Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival. World J Surg 30:780-786.
14. Segal K, Shpitzer T, Hazan A, Bachar G, Marshak G, Popovtzer A 2006 Invasive well-differentiated thyroid carcinoma: effect of treatment modalities on outcome. Otolaryngol Head Neck Surg 134:819-822.
15. Kowalski LP, Filho JG 2002 Results of the treatment of locally invasive thyroid carcinoma. Head Neck 24:340-344.
16. Grillo HC, Suen HC, Mathisen DJ, Wain JC 1992 Resectional management of thyroid carcinoma invading the airway. Ann Thorac Surg 54:3-9; discussion 9-10.
17. Nishida T, Nakao K, Hamaji M 1997 Differentiated thyroid carcinoma with airway invasion: indication for tracheal resection based on the extent of cancer invasion. J Thorac Cardiovasc Surg 114:84-92.
18. Siironen P, Hagstrm J, Menp HO, Louhimo J, Heikkil A, Heiskanen I, Arola J, Haglund C 2010 Anaplastic and poorly differentiated thyroid carcinoma: therapeutic strategies and treatment outcome of 52 consecutive patients. Oncology 79:400-408.
19. Andersen PE, Kinsella J, Loree TR, Shaha AR, Shah JP 1995 Differentiated carcinoma of the thyroid with extrathyroidal extension. Am J Surg 170:467-470.
20. Sampson E, Brierley JD, Le LW, Rotstein L, Tsang RW 2007 Clinical management and outcome of papillary and follicular (differentiated) thyroid cancer presenting with distant metastasis at diagnosis. Cancer 110:1451-1456.
21. Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, Caillou B, Ricard M, Lumbroso JD, De Vathaire F, Schlumberger M 2006 Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab 91:2892-2899.
22. Lee J, Soh EY 2010 Differentiated thyroid carcinoma presenting with distant metastasis at initial diagnosis clinical outcomes and prognostic factors. Ann Surg 251:114-119.
23. Sakamoto A, Kasai N, Sugano H 1983 Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 52:1849-1855.
24. Jung TS, Kim TY, Kim KW, Oh YL, Park do J, Cho BY, Shong YK, Kim WB, Park YJ, Jung JH, Chung JH 2007 Clinical features and prognostic factors for survival in patients with poorly differentiated thyroid carcinoma and comparison to the patients with the aggressive variants of papillary thyroid carcinoma. Endocr J 54:265-274.
25. Sherman SI 2011 Targeted therapies for thyroid tumors. Mod Pathol 24(Suppl 2):S44-52.
26. O'Reilly MS 2006 Radiation combined with antiangiogenic and antivascular agents. Semin Radiat Oncol 16:45-50.